Literature DB >> 20419818

Characterization of common and rare human papillomaviruses in Portuguese women by the polymerase chain reaction, restriction fragment length polymorphism and sequencing.

Rui Jorge Nobre1, Eugénia Cruz, Odete Real, Luís Pereira de Almeida, Teresa C Martins.   

Abstract

The present study aimed to provide additional information on the prevalence of mucosal human papillomavirus (HPV) types in Portuguese women by using polymerase chain reaction, restriction fragment length polymorphism and sequencing. HPV was detected in 15.5% (15/97) of the control samples, 23.5% (12/51) of atypical squamous cells of undetermined significance, 52.8% (28/53) of low-grade lesions, 82.4% (28/34) of high-grade lesions, and 100% (44/44) of carcinomas. Overall, 28 HPV types were detected: 11 high-risk (HPV 16, 18, 31, 33, 35, 39, 45, 52, 56, 58, and 59), 3 probable high-risk (HPV 53, 66, and 73), 6 low-risk (HPV 6, 11, 44, 61, 70, and 81), and 8 unknown-risk types (HPV 34, 62, 67, 71, 83, 84, 102, and 108). The most prevalent type was HPV 16, detected in 33.8% of women infected with HPV, followed by HPV 58 (9.2%), HPV 33 (7.0%), HPV 18 (6.3%), HPV 53 (5.6%), HPV 31 and 56 (4.9% each), HPV 6 (3.5%), and HPV 66 and 81 (2.8% each). Of 44 cervical carcinoma samples, 71% were associated with HPV 16 (60%) and HPV 18 (11.1%), followed by the high-risk types 33 (11.1%), 35 (4.4%), 45 (4.4%), and 56 (2.2%), the probable high-risk type 53 (4.4%) and the unknown-risk type 67 (2.2%). This study provides information on the most common HPV types in Portuguese women and suggests that the current prophylactic HPV 16/18 vaccine may be useful for the prevention of cervical cancer in this population. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20419818     DOI: 10.1002/jmv.21756

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

1.  WT1, MSH6, GATA5 and PAX5 as epigenetic oral squamous cell carcinoma biomarkers - a short report.

Authors:  Ilda Patrícia Ribeiro; Francisco Caramelo; Francisco Marques; Ana Domingues; Margarida Mesquita; Leonor Barroso; Hugo Prazeres; Maria José Julião; Isabel Poiares Baptista; Artur Ferreira; Joana Barbosa Melo; Isabel Marques Carreira
Journal:  Cell Oncol (Dordr)       Date:  2016-08-04       Impact factor: 6.730

2.  Genetic gains and losses in oral squamous cell carcinoma: impact on clinical management.

Authors:  Ilda Patrícia Ribeiro; Francisco Marques; Francisco Caramelo; João Pereira; Miguel Patrício; Hugo Prazeres; José Ferrão; Maria José Julião; Miguel Castelo-Branco; Joana Barbosa de Melo; Isabel Poiares Baptista; Isabel Marques Carreira
Journal:  Cell Oncol (Dordr)       Date:  2013-12-19       Impact factor: 6.730

3.  The cytology and DNA detection by the PapilloCheck(®) test in the diagnosis of human papillomavirus infection.

Authors:  L Vieira; A Almeida
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-03-13

4.  Genetic imbalances detected by multiplex ligation-dependent probe amplification in a cohort of patients with oral squamous cell carcinoma-the first step towards clinical personalized medicine.

Authors:  Ilda Patrícia Ribeiro; Francisco Marques; Francisco Caramelo; José Ferrão; Hugo Prazeres; Maria José Julião; Widad Rifi; Suvi Savola; Joana Barbosa de Melo; Isabel Poiares Baptista; Isabel Marques Carreira
Journal:  Tumour Biol       Date:  2014-01-31

5.  Oncogenic HPV Types Infection in Adolescents and University Women from North Portugal: From Self-Sampling to Cancer Prevention.

Authors:  Jani Silva; Joana Ribeiro; Hugo Sousa; Fátima Cerqueira; Ana Luisa Teixeira; Ines Baldaque; Teresa Osório; Rui Medeiros
Journal:  J Oncol       Date:  2011-11-28       Impact factor: 4.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.